ACETO Comments on Legal Proceedings affecting the Generic Pharmaceuticals Industry
December 15, 2016 18:17 ET
|
ACETO CORPORATION
PORT WASHINGTON, N.Y., Dec. 15, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET) commented today on recent announcements impacting the generic pharmaceuticals industry. The State of...
ACETO Board of Directors Declares Quarterly Cash Dividend
December 01, 2016 14:10 ET
|
ACETO CORPORATION
PORT WASHINGTON, N.Y., Dec. 01, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health...
ACETO Subsidiary, Rising Pharmaceuticals, to Launch Erythromycin and Benzoyl Peroxide Topical Gel USP, 3%/5%
November 17, 2016 16:30 ET
|
ACETO CORPORATION
PORT WASHINGTON, N.Y., Nov. 17, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health...
ACETO Subsidiary, Rising Pharmaceuticals, to Launch Oxybutynin Chloride Extended-Release Tablets, USP
November 14, 2016 09:45 ET
|
ACETO CORPORATION
PORT WASHINGTON, N.Y., Nov. 14, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health...
ACETO Corporation to Hold Conference Call on November 3, 2016 at 9:00 a.m. ET
November 02, 2016 16:20 ET
|
ACETO CORPORATION
PORT WASHINGTON, N.Y., Nov. 02, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sales and distribution of Human Health...
ACETO Reports Fiscal 2017 First Quarter Results
November 02, 2016 16:17 ET
|
ACETO CORPORATION
Separately Company Announces Acquisition of Generic Products and Related Assets of Citron Pharma Management to Host Conference Call on November 3, 2016 at 9:00 a.m. ET PORT WASHINGTON, N.Y., Nov. ...
ACETO to Acquire Generic Products and Related Assets of Citron Pharma and Lucid Pharma
November 02, 2016 16:15 ET
|
ACETO CORPORATION
Combines complementary asset-light business models, products and partnersAdds significant value of 47 commercialized generic drug products, and 31 approved and yet-to-be launched productsAdds 33...
ACETO Corporation Schedules First Quarter Fiscal 2017 Financial Results News Release and Conference Call
October 21, 2016 16:05 ET
|
ACETO CORPORATION
PORT WASHINGTON, N.Y., Oct. 21, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sales and distribution of Human Health...
ACETO Subsidiary, Rising Pharmaceuticals, to Launch Fluocinolone Acetonide OTIC Oil, 0.01%
September 16, 2016 09:02 ET
|
ACETO CORPORATION
PORT WASHINGTON, N.Y., Sept. 16, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health...
ACETO Appoints William C. Kennally, III to the Board of Directors
September 06, 2016 15:30 ET
|
ACETO CORPORATION
PORT WASHINGTON, N.Y., Sept. 06, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health...